欢迎来到天天文库
浏览记录
ID:54980301
大小:294.35 KB
页数:4页
时间:2020-05-07
《抑肝扶脾清热利湿法对广东地区腹泻型肠易激综合征患者血浆胃肠激素含量的影响-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、第21卷第1O期第509页中国中西医结合消化杂志VO121N010P5092013年1O月ChinJIntegrTradWestMedDigoct2013doi:10.3969/j.issn.1671—038X.2013.10.002抑肝扶脾清热利湿法对广东地区腹泻型肠易激综合征患者血浆胃肠激素含量的影响常东,李健,冯春霞。,唐纯志。,刘予志。,樊亚巍,李辉,何方(武警广东边防总队医院消化内科,广东深圳518029;深圳市中医院消化内科,广东深圳518033;。广州中医药大学科研处,广东广州510407)摘要:[目的]观察抑肝扶脾清热利湿法对广东地区腹泻型肠易激综合征(dia
2、rrheatypeirritablebowelsyn—drome,mS-D)患者血浆胃动素(MTL)、血管活性肠肽(VIP)、生长抑素(SS)、胆囊收缩素(CCK)的影响,并探讨其作用机制。[方法"]160例IK%D患者随机分为2组,中药组采用易激灵2号方,煎取200ml,早晚分服;西药组口服马来酸曲美布丁片(商品名:舒丽启能)0.1g/次、枯草杆菌二联活菌肠溶胶囊(商品名:美常安)0.5g/次,3次/d;2组疗程均为4周。另选2O例健康体检者为正常对照组。[结果]IBD患者血浆CCK、MTL水平较正常对照组明显增高(P3、TL水平明显降低(P4、swithdiarrheatypeirritablebowelsyndromeinGuangdongdistrictCHANGDong,LIJian,FENGChun—xia。,TANGChun—zhi。LIUZi—zhi。FANYa—weiLIHuiHEFang(DepartmentofDigestiveDiseases,ShenzhenHospital,ChinesePeople’SArmedPoliceForces,Shenzhen518029,China;。DepartmentofDigestiveDiseases,ShenzhenHospitalofTraditio5、nlChineseMedicine,Shenzhen518033,China;。ScientificResearchOffice,GuangzhouUniversityofChineseMedicine,Guangzhou510407,China)Correspondingauthor:CHANGDong,E—mail:wjchangdong@sina.cornAbstract:I-Objective]Toobservetheeffectofsoothingliverandinvigoratingspleen,clearingawayheatandeliminatingdam6、pnessonMTL,VIP,SS,CCKinpatientswithdiarrheatypeirritablebowelsyndrome(IBD)inGuangdong.[Methods]Thetotalof160patientswithIBDwereassignedto2groups:ChinesemedicineGroupwastreatedwithYUILING-2,decocted200ml,twicedailybyoraladministration;WesternmedicineGroupwastreatedwithTrimebutineMaleateTable7、ts0.1gandMeichangan0.5g,3timesdailybyoraladministration.Thetherapeuticcoursewas4weeksfora11.JResultslTheplasmaCCK,MTLweresig—nificantlyhigherinIBS-Dpatientsthaninthenormalgroup(P~0.01).Aftertreatment。theplasmaCCK。MTLweresignificantlylowerinIBDpatientsofC
3、TL水平明显降低(P4、swithdiarrheatypeirritablebowelsyndromeinGuangdongdistrictCHANGDong,LIJian,FENGChun—xia。,TANGChun—zhi。LIUZi—zhi。FANYa—weiLIHuiHEFang(DepartmentofDigestiveDiseases,ShenzhenHospital,ChinesePeople’SArmedPoliceForces,Shenzhen518029,China;。DepartmentofDigestiveDiseases,ShenzhenHospitalofTraditio5、nlChineseMedicine,Shenzhen518033,China;。ScientificResearchOffice,GuangzhouUniversityofChineseMedicine,Guangzhou510407,China)Correspondingauthor:CHANGDong,E—mail:wjchangdong@sina.cornAbstract:I-Objective]Toobservetheeffectofsoothingliverandinvigoratingspleen,clearingawayheatandeliminatingdam6、pnessonMTL,VIP,SS,CCKinpatientswithdiarrheatypeirritablebowelsyndrome(IBD)inGuangdong.[Methods]Thetotalof160patientswithIBDwereassignedto2groups:ChinesemedicineGroupwastreatedwithYUILING-2,decocted200ml,twicedailybyoraladministration;WesternmedicineGroupwastreatedwithTrimebutineMaleateTable7、ts0.1gandMeichangan0.5g,3timesdailybyoraladministration.Thetherapeuticcoursewas4weeksfora11.JResultslTheplasmaCCK,MTLweresig—nificantlyhigherinIBS-Dpatientsthaninthenormalgroup(P~0.01).Aftertreatment。theplasmaCCK。MTLweresignificantlylowerinIBDpatientsofC
4、swithdiarrheatypeirritablebowelsyndromeinGuangdongdistrictCHANGDong,LIJian,FENGChun—xia。,TANGChun—zhi。LIUZi—zhi。FANYa—weiLIHuiHEFang(DepartmentofDigestiveDiseases,ShenzhenHospital,ChinesePeople’SArmedPoliceForces,Shenzhen518029,China;。DepartmentofDigestiveDiseases,ShenzhenHospitalofTraditio
5、nlChineseMedicine,Shenzhen518033,China;。ScientificResearchOffice,GuangzhouUniversityofChineseMedicine,Guangzhou510407,China)Correspondingauthor:CHANGDong,E—mail:wjchangdong@sina.cornAbstract:I-Objective]Toobservetheeffectofsoothingliverandinvigoratingspleen,clearingawayheatandeliminatingdam
6、pnessonMTL,VIP,SS,CCKinpatientswithdiarrheatypeirritablebowelsyndrome(IBD)inGuangdong.[Methods]Thetotalof160patientswithIBDwereassignedto2groups:ChinesemedicineGroupwastreatedwithYUILING-2,decocted200ml,twicedailybyoraladministration;WesternmedicineGroupwastreatedwithTrimebutineMaleateTable
7、ts0.1gandMeichangan0.5g,3timesdailybyoraladministration.Thetherapeuticcoursewas4weeksfora11.JResultslTheplasmaCCK,MTLweresig—nificantlyhigherinIBS-Dpatientsthaninthenormalgroup(P~0.01).Aftertreatment。theplasmaCCK。MTLweresignificantlylowerinIBDpatientsofC
此文档下载收益归作者所有